🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The brilliant light of our family has dimmed his light for us in this life,” his family stated. “After a lengthy and brave struggle with the disease, we are heartbroken to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his innovative neo-soul sound and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on the R&B charts, went platinum later that year, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The album premiered at the top spot on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo retreated from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the R&B chart and a Grammy for Best R&B Album.

Once more, in his own enigmatic way, D’Angelo had limited public outings in the following years.

The singer was scheduled as a top act for the 2025 music event, but his performance was canceled, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had reportedly been hospitalized for an extended period and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was cut short.

“We are grieved that he can only leave cherished moments with his loved ones, but we are eternally grateful for the heritage of extraordinarily moving music he leaves behind,” his family said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic cancer affects the pancreas, a small organ that generates insulin and is vital in breaking down food, among additional roles. The position and dimensions of the pancreas in the human system make it more challenging to detect cancer.

Although pancreatic cancer accounts for only about 3% of cancer diagnoses annually in the U.S., it is causes 7% of malignancy fatalities.

Nearly seventy thousand people will be found to have pancreatic cancer and about fifty-two thousand will succumb to the disease in 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and poor therapies, and a smaller window to make a meaningful impact on the lives of patients,” said a medical oncologist.

Because this disease rarely causes initial signs, it’s often identified only once the condition is late-stage. Although a individual has indicators they are often vague and may be mistaken for a several everyday ailments.

“As of yet, there is no good way to detect this malignancy in the early stages, apart from listening to your body and consulting your doctor if there are new or unusual symptoms,” said a medical director.

Frequent indicators of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• dark urine
• light-colored or greasy stools
• diarrhea
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 age bracket. However, numerous malignancies, including this type, have become increasingly prevalent in younger adults.

“This disease diagnosed prior to fifty is deemed rare, yet alarmingly, doctors are beginning to see a growing number of younger patients affected by this disease,” commented a specialist.

Family History Impacts Disease Probability

Without effective detection methods for pancreatic cancer, experts stressed the significance of knowing your family’s health background. Some risk factors, such as tobacco use and excess weight also have an influence in the development of this disease.

African Americans have the highest incidence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward reducing one’s risk of pancreatic cancer is assessing individual susceptibility. Individuals should examine their genetic background, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their vulnerability,” said a specialist.

Hereditary elements are associated with as much as 10% of all this malignancy instances. If a relative in your family has had this disease, you may want to consider genetic testing.

“For people with a family history of this condition or those having high risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he explained.

For those looking to reduce their risk, habit adjustments may have an effect. The best step you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Heavy drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or avoiding alcohol may help reduce your risk.

Managing your weight or losing weight may also aid reduce your risk. People with excess weight are twenty percent more prone to develop pancreatic cancer. This malignancy also is more frequent in those with diabetes, and weight loss can also lower the chance of adult-onset diabetes.

Despite this disease’s poor prognosis, there is still hope.

“We are making progress with therapies and more recent mixed drug treatments. There are developing precision medicines that already are showing results,” remarked a specialist.

For numerous people, however, awareness about this rare but {dev